Abstract:
A genetically modified zebrafish embryo, comprising a HBNF cDNA or a NGF cDNA or a GDNF cDNA together with a cDNA encoding green fluorescent protein (GFP) so as to induce neurite outgrowth during said zebrafish embryonic development, and a method of using such genetically modified zebrafish embryo to identify a therapeutic agent are disclosed.
Abstract:
A vacuum glass structure comprising two glass substrates maintained at an substantially constant interval by a glass frit paste sealingly adhering to the peripheries thereof, forming a hermetically sealed vacuum room. A receiving gap is formed at the periphery of the glass substrate. The internal surface of the glass structure further includes an air chamber and a glass tube groove for receiving a pumping tube. The pumping tube can be placed inside the receiving gap with the internal end of the pumping tube extending from the receiving gap through the glass tube groove into the air chamber. The external end of the pumping tube constitutes a hermetic seal retained within the geometric boundary of the receiving gap. The air chamber structure may improve air transferring efficiency and prevents problems such as blockage in the pumping tube, thus enabling an increase in production yield.
Abstract:
Two pairs of PCR primer mixtures to be used to detect baculovirus infection: (i) a mixture of 25 to 35-base oligonucleotides including, respectively, 5'-TTTTGACGCAAATYYTAGACGCCGT-3' (SEQ ID NO: 1), and a mixture of 19 to 29-base oligonucleotides, including, respectively, 5'-TCARYATKGATTGAATWTC-3' (SEQ ID NO: 2); and (ii) a mixture of 30 to 40-base oligonucleotides, including, respectively, 5'-TAYGTGTACGACAACAARTAY-3' (SEQ ID NO: 3), and a mixture of 30 to 40-base oligonucleotides, including, respectively, 5'-GCGTCKGGYGCAAAYTCYTTWACY-3' (SEQ ID NO: 7).
Abstract translation:用于检测杆状病毒感染的两对PCR引物混合物:(i)包含分别为5'-TTTTGACGCAAATYYTAGACGCCGT-3'(SEQ ID NO:1)的25至35个碱基的寡核苷酸的混合物和19 至29个碱基的寡核苷酸,分别包括5'-TCARYATKGATTGAATWTC-3'(SEQ ID NO:2); 和(ii)30至40个碱基寡核苷酸的混合物,分别包括5'-TAYGTGTACGACAACAARTAY-3'(SEQ ID NO:3)和30至40个碱基寡核苷酸的混合物,分别包含5' -GCGTCKGGYGCAAAYTCYTTWACY-3'(SEQ ID NO:7)。
Abstract:
An optical diffuser structure for field emitting display element provides uniform lightness contrast to a display, and includes a glass substrate as main body, wherein plural black stripe blocking layers is arranged on the panel of the substrate for covering the light diffusing path of the display element, a transparent glue layer being further arranged on the surfaces of the black stripe blocking layer and glass substrate, thus the black stripe blocking layer is protected from the damage caused by sandblasting process, at last, a nebulized surface is formed on the transparent glue layer, thereby, through the diffuser structure, the light generated by the display element possesses a uniformity without any reduction and loss of lightness.
Abstract:
The present invention provides a method utilizing mammalian expression system for generating virus-like particles (VLPs) of mammalian-hosted viruses, particularly SARS-CoV. The method of the present invention involves expression of viral structural proteins in Vero cells and thereby obtaining recombinant VLPs in the culture medium. SARS-VLPs generated by the method of the present invention are highly immunogenic and can elicit not only humoral but also cellular immune responses in a mammal.
Abstract:
Isolated polypeptides containing one of SEQ ID NOs: 1-11. Also disclosed are (i) isolated nucleic acids encoding the polypeptides and related expression vectors and host cells; (ii) purified antibodies that recognize the polypeptides; and (iii) methods of producing the polypeptides, diagnosing infection with a coronavirus, and producing the antibodies.
Abstract translation:含有SEQ ID NO:1-11之一的分离的多肽。 还公开了(i)编码多肽和相关表达载体和宿主细胞的分离的核酸; (ii)识别多肽的纯化抗体; 和(iii)产生多肽的方法,诊断冠状病毒的感染和产生抗体。
Abstract:
A genetically modified zebrafish embryo, comprising a HBNF cDNA or a NGF cDNA or a GDNF cDNA together with a cDNA encoding green fluorescent protein (GFP) so as to induce neurite outgrowth during said zebrafish embryonic development, and a method of using such genetically modified zebrafish embryo to identify a therapeutic agent are disclosed.